Vinge has advised Apotea AB (publ) (“Apotea”) in connection with its listing on Nasdaq Stockholm. Th…
Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm,…
Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which…
In total, 7.7 million shares were placed at a price of SEK 57.50 per share, corresponding to a total…
